Diminished monocyte response in severe COVID-19 patients

被引：0

作者：

Davis-Gardner, Meredith E. ^{[1
,2
]}

Edara, Venkata ^{[1
,2
]}

Lai, Lilin ^{[1
,2
]}

Jin, Fengzhi ^{[2
,3
]}

Floyd, Katharine ^{[1
,2
]}

Nyhoff, Lindsay ^{[1
,4
]}

Mantus, Grace ^{[1
,4
]}

Adelman, Max ^{[5
]}

Pellegrini, Kathryn ^{[2
,6
]}

Chirkova, Tatiana ^{[1
,4
]}

Kissick, Haydn ^{[1
,7
]}

Bosinger, Steven ^{[2
]}

Anderson, Larry ^{[1
,4
]}

Rouphael, Nadine ^{[5
]}

Ahmed, Rafi ^{[1
]}

Wrammert, Jens ^{[1
,4
]}

Grakoui, Arash ^{[2
,8
]}

Suthar, Mehul S. ^{[2
,9
]}

机构：

[1] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA

[2] Emory Vaccine Ctr, Yerkes Primate Res Ctr, Atlanta, GA USA

[3] Emory Univ, Atlanta, GA 30322 USA

[4] Emory Univ, Dept Pediat, Childrens Healthcare Atlanta, Ctr Childhood Infect & Vaccines, Atlanta, GA 30322 USA

[5] Emory Univ, Sch Med, Dept Med, Div Infect Dis,Hope Clin,Emory Vaccine Ctr, Atlanta, GA 30322 USA

[6] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA

[7] Emory Univ, Dept Urol, Atlanta, GA 30322 USA

[8] Emory Univ, Dept Med, Atlanta, GA 30322 USA

[9] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA

来源：

JOURNAL OF IMMUNOLOGY | 2021年 / 206卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页数：2

共 50 条

[1] Impaired mucosal IgA response in patients with severe COVID-19
Yaugel-Novoa, Melyssa
Noailly, Blandine
Jospin, Fabienne
Pizzorno, Andres
Traversier, Aurelien
Pozzetto, Bruno
Waeckel, Louis
Longet, Stephanie
Pillet, Sylvie
Botelho-Nevers, Elisabeth
Rosa-Calatrava, Manuel
Bourlet, Thomas
Paul, Stephane
EMERGING MICROBES & INFECTIONS, 2024, 13 (01)
[2] As a matter of fat: Leptin, monocyte hyperactivation, and COVID-19 A commentary to "Leptin correlates with monocytes activation and severe condition in COVID-19 patients"
Recchiuti, Antonio
JOURNAL OF LEUKOCYTE BIOLOGY, 2021, 110 (01) : 7 - 8
[3] Remdesivir for patients with severe COVID-19
Augustin, M.
Hallek, M.
Nitschmann, S.
INTERNIST, 2020, 61 (06): : 644 - 645
[4] Clarifications on Technologies to Optimize Care of Severe COVID-19 Patients Response
Rubulotta, Francesca
Soliman-Aboumarie, Hatem
Filbey, Kevin
Geldner, Goetz
Kuck, Kai
Ganau, Mario
Hemmerling, Thomas M.
ANESTHESIA AND ANALGESIA, 2020, 131 (04): : E193 - E195
[5] CLINICAL RESPONSE PREDICTORS OF TOCILIZUMAB THERAPY IN PATIENTS WITH SEVERE COVID-19
Schmidt, W.
Pawlak-Bus, K.
Leszczynski, P.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 967 - 968
[6] Unraveling the Immune Response in Severe COVID-19
Lucie Rodriguez
Petter Brodin
Journal of Clinical Immunology, 2020, 40 : 958 - 959
[7] An aberrant inflammatory response in severe COVID-19
Merad, Miriam
Subramanian, Aruna
Wang, Taia T.
CELL HOST & MICROBE, 2021, 29 (07) : 1043 - 1047
[8] Unraveling the Immune Response in Severe COVID-19
Rodriguez, Lucie
Brodin, Petter
JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (07) : 958 - 959
[9] Response to Prone Position in COVID-19 and Non-COVID-19 Patients with Severe ARDS Supported by vvECMO
Textoris, Laura
Gragueb-Chatti, Ines
Daviet, Florence
Valera, Sabine
Sanz, Celine
Papazian, Laurent
Forel, Jean-Marie
Hraiech, Sami
Roch, Antoine
Guervilly, Christophe
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (12)
[10] Metatranscriptomic analysis of host response and vaginal microbiome of patients with severe COVID-19
Xiao, Meng
Lu, Bo
Ding, Rui
Liu, Xia
Wu, Xian
Li, Yaqian
Liu, Xudong
Qiu, Lin
Zhang, Zhibo
Xie, Jing
Chen, Yu
Zhang, Dong
Dong, Liting
Zhang, Meiling
Peng, Jinying
Yang, Hua
Kudihna, Timothy
Xu, Yingchun
Li, Taisheng
Yi, Chengqi
Zhu, Lan
SCIENCE CHINA-LIFE SCIENCES, 2022, 65 (07) : 1473 - 1476

← 1 2 3 4 5 →